{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:20:38Z","timestamp":1763641238236},"reference-count":9,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Postgraduate Medicine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.3810\/pgm.2008.07.1789","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T16:28:42Z","timestamp":1221582522000},"page":"42-45","source":"Crossref","is-referenced-by-count":3,"title":["Concerns About the Safety of Obesity Agents From a Manufacturing Perspective"],"prefix":"10.3109","volume":"120","author":[{"given":"Isadore","family":"Kanfer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"issue":"11","key":"CIT0001","first-page":"528","volume":"17","year":"2007","journal-title":"AIDS Reader."},{"issue":"7","key":"CIT0002","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/apc.2007.9975","volume":"21","author":"Viracept contaminated in Europe.","year":"2007","journal-title":"AIDS Patient Care STDs."},{"issue":"9","key":"CIT0003","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archinte.164.9.994","volume":"164","author":"Arterburn DE","year":"2004","journal-title":"Arch Intern Med."},{"issue":"3","key":"CIT0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/0960327105ht510oa","volume":"24","author":"Kim EJ","year":"2005","journal-title":"Human Exper Toxicol."},{"key":"CIT0007","volume-title":"CPMP\/ SWP\/5199\/02","author":"European Medicines Evaluation Agency.","year":"2006"},{"issue":"17","key":"CIT0008","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMp0802041","volume":"358","author":"Schweitzer SO.","year":"2008","journal-title":"N Engl J Med."},{"issue":"1","key":"CIT0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2005.12.001","volume":"28","author":"Verbeeck RK","year":"2006","journal-title":"Eur J Pharm Sci."},{"key":"CIT0010","first-page":"31","volume-title":"Generic Drug Product Development: Bioequivalence Issues.","author":"Walker RB","year":"2008"},{"issue":"1","key":"CIT0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yrtph.2006.02.003","volume":"45","author":"Snodin DJ.","year":"2006","journal-title":"Reg Toxicol Pharmacol."}],"container-title":["Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3810\/pgm.2008.07.1789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T07:46:50Z","timestamp":1497772010000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3810\/pgm.2008.07.1789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":9,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,6,30]]},"published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.3810\/pgm.2008.07.1789"],"URL":"https:\/\/doi.org\/10.3810\/pgm.2008.07.1789","relation":{},"ISSN":["0032-5481","1941-9260"],"issn-type":[{"value":"0032-5481","type":"print"},{"value":"1941-9260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}